HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

diisoeugenol

structure given in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Fujisawa, Seiichiro: 2 articles (11/2005 - 02/2005)
2.	Murakami, Yukio: 2 articles (11/2005 - 02/2005)
3.	Atsumi, Toshiko: 1 article (11/2005)
4.	Shibuya, Kazutoshi: 1 article (11/2005)
5.	Tonosaki, Keiichi: 1 article (11/2005)
6.	Hirata, Atsushi: 1 article (02/2005)
7.	Shoji, Masao: 1 article (02/2005)
8.	Tanaka, Shoji: 1 article (02/2005)
9.	Yokoe, Ichiro: 1 article (02/2005)

Related Diseases

1.	Neoplasms (Cancer) 11/01/2005 - "The cytotoxicity of curcumin and a-diisoeugenol against human promyelocytic leukemia cells (HL-60 cells) and human submandibular cancer cells (HSG cells) was similar (CC50 1-3 microM). "
2.	Leukemia 11/01/2005 - "The cytotoxicity of curcumin and a-diisoeugenol against human promyelocytic leukemia cells (HL-60 cells) and human submandibular cancer cells (HSG cells) was similar (CC50 1-3 microM). "
3.	Inflammation (Inflammations) 02/15/2005 - "Thus, we further synthesized dehydrodiisoeugenol and alpha-diisoeugenol from isoeugenols, and investigated whether these dimers could inhibit LPS-stimulated nuclear factor kappa B (NF-kappaB) activation and cyclooxygenase (COX)-2 gene expression, both of which are closely involved in inflammation and mutagenesis. "

Related Drugs and Biologics

1.	NF-kappa B (NF-kB)
2.	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
3.	Curcumin
4.	dehydrodiisoeugenol